학술논문
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
Document Type
Article
Author
Source
Neurology; 3/12/2024, Vol. 102 Issue 5, p1-12, 12p
Subject
Language
ISSN
00283878